David Weill, Director at TransMedics Group, Inc. (TMDX), sold 2,386 shares at $141.65 ($338K) on 2024-05-29, disclosed to the SEC on 2024-05-31.
Open-market sale of $338k TMDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $141.65 | 1,193 | $169K | 50.0% |
| 2 | $141.65 | 1,193 | $169K | 50.0% |
| Total | $141.65 avg | 2,386 | $338K | 100% |
| Filing → |
| TMDX | SELL | 2025-12-05 | $1.4M | — | Filing → |
| TMDX | SELL | 2025-05-23 | $181K | — | Filing → |
| TMDX | SELL | 2024-05-14 | $325K | — | Filing → |